Tissue firms partner
This article was originally published in The Gray Sheet
Executive Summary
Regeneration Technologies and Tutogen Medical enter a mutual sourcing agreement Nov. 6 whereby RTI gains access to soft tissue used in sports medicine surgeries recovered by Tutogen's recovery partners, and Tutogen obtains the rights to dermis, fascia and pericardium recovered by RTI Donor Services agencies. The partnership enables maximum use of donated tissue, the firms say...
You may also be interested in...
Regeneration/Tutogen Merger Creates Broad Biologic Implant Portfolio
Regeneration Technologies Inc. will maintain both the BioCleanse and Tutoplast tissue sterilization processes for making biologic implants following its acquisition of Tutogen in a $263 million stock-swap deal, announced Nov. 13
As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure
The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.